B细胞-话题@MedSci

#B细胞#

314篇内容 | 4765人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1273300, encodeId=314f12e3300be, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：Parsaclisib，高选择性PI3Kδ抑制剂，可有效治疗复发性或难治性B细胞NHL, objectType=article, longId=163405, objectId=55c3163405ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55c3163405ab, replyNumber=0, likeNumber=80, createdTime=2019-04-03, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55c3163405ab, moduleTitle=Blood：Parsaclisib，高选择性PI3Kδ抑制剂，可有效治疗复发性或难治性B细胞NHL, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55c3163405ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273299, encodeId=e22d12e3299bd, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NCCN临床实践指南：B细胞淋巴瘤（2019.V2）, objectType=article, longId=163343, objectId=63e8163343c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63e8163343c3, replyNumber=0, likeNumber=20, createdTime=2019-04-01, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63e8163343c3, moduleTitle=NCCN临床实践指南：B细胞淋巴瘤（2019.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63e8163343c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273298, encodeId=c14b12e3298c0, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：Venetoclax联合R-CHOP可安全有效治疗弥漫性大B细胞淋巴瘤, objectType=article, longId=162820, objectId=0e731628209a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e731628209a, replyNumber=0, likeNumber=76, createdTime=2019-03-25, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e731628209a, moduleTitle=Blood：Venetoclax联合R-CHOP可安全有效治疗弥漫性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e731628209a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273297, encodeId=d20312e329708, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Ann Rheum Dis：使用靶向B细胞的ianalumab（VAY736）治疗原发性干燥综合征, objectType=article, longId=161682, objectId=8b5b16168264, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b5b16168264, replyNumber=0, likeNumber=64, createdTime=2019-03-07, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b5b16168264, moduleTitle=Ann Rheum Dis：使用靶向B细胞的ianalumab（VAY736）治疗原发性干燥综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b5b16168264)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273296, encodeId=fe4d12e32966a, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=鞍区粘膜相关性B细胞淋巴瘤1例, objectType=article, longId=161101, objectId=3eef16110132, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3eef16110132, replyNumber=0, likeNumber=92, createdTime=2019-02-27, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3eef16110132, moduleTitle=鞍区粘膜相关性B细胞淋巴瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3eef16110132)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273295, encodeId=c17f12e3295fe, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=加拿大批准Yescarta（Axicabtagene Ciloleucel）CAR T疗法治疗成人复发或难治性大B细胞淋巴瘤, objectType=article, longId=160891, objectId=16d216089137, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16d216089137, replyNumber=0, likeNumber=58, createdTime=2019-02-25, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16d216089137, moduleTitle=加拿大批准Yescarta（Axicabtagene Ciloleucel）CAR T疗法治疗成人复发或难治性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16d216089137)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273294, encodeId=560912e3294a4, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=AP&T：慢性乙型肝炎会增加B细胞非霍奇金淋巴瘤和多发性骨髓瘤发生风险, objectType=article, longId=160233, objectId=01b116023331, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01b116023331, replyNumber=0, likeNumber=70, createdTime=2019-02-18, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01b116023331, moduleTitle=AP&T：慢性乙型肝炎会增加B细胞非霍奇金淋巴瘤和多发性骨髓瘤发生风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01b116023331)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273293, encodeId=8cc712e329321, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Stem Cell Reports：科学家在小鼠体内制造出可供移植功能性B细胞, objectType=article, longId=160035, objectId=55b1160035bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55b1160035bb, replyNumber=0, likeNumber=82, createdTime=2019-02-16, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55b1160035bb, moduleTitle=Stem Cell Reports：科学家在小鼠体内制造出可供移植功能性B细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55b1160035bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273292, encodeId=c2d512e3292af, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：MHC II类细胞可自主调节正常和恶性B细胞的自我更新和分化, objectType=article, longId=159604, objectId=43ae1596044f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43ae1596044f, replyNumber=0, likeNumber=99, createdTime=2019-02-09, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43ae1596044f, moduleTitle=Blood：MHC II类细胞可自主调节正常和恶性B细胞的自我更新和分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43ae1596044f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273291, encodeId=6cd012e3291ac, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=INT J LAB HEMATOL：利用CD81/CD58的表达率很容易从B细胞祖细胞急性淋巴细胞白血病患者淋巴母细胞中识别造血细胞, objectType=article, longId=159378, objectId=d85f1593e830, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d85f1593e830, replyNumber=0, likeNumber=61, createdTime=2019-02-03, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d85f1593e830, moduleTitle=INT J LAB HEMATOL：利用CD81/CD58的表达率很容易从B细胞祖细胞急性淋巴细胞白血病患者淋巴母细胞中识别造血细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d85f1593e830)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273290, encodeId=e84012e3290de, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=INT J LAB HEMATOL：对286个成熟B细胞肿瘤的整合流式细胞术分析显示，CD13可作为诊断亚型的有用标记, objectType=article, longId=159375, objectId=c0fc1593e543, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0fc1593e543, replyNumber=0, likeNumber=59, createdTime=2019-02-03, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0fc1593e543, moduleTitle=INT J LAB HEMATOL：对286个成熟B细胞肿瘤的整合流式细胞术分析显示，CD13可作为诊断亚型的有用标记, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0fc1593e543)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273289, encodeId=fcf412e328924, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=2019 BSH更佳实践指南：原发性纵膈B细胞淋巴瘤的管理, objectType=article, longId=159138, objectId=e15f159138c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e15f159138c6, replyNumber=0, likeNumber=30, createdTime=2019-01-30, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e15f159138c6, moduleTitle=2019 BSH更佳实践指南：原发性纵膈B细胞淋巴瘤的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e15f159138c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273288, encodeId=503c12e3288e8, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=膀胱弥漫大B细胞淋巴瘤侵及回肠1例, objectType=article, longId=158745, objectId=d7d4158e45d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7d4158e45d0, replyNumber=0, likeNumber=74, createdTime=2019-01-25, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7d4158e45d0, moduleTitle=膀胱弥漫大B细胞淋巴瘤侵及回肠1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7d4158e45d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273287, encodeId=e46212e32878f, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Lancet Haematol：MYC基因重排侵袭性B细胞淋巴瘤可考虑剂量调整的EPOCH-R方案, objectType=article, longId=158333, objectId=632d1583337f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=632d1583337f, replyNumber=0, likeNumber=66, createdTime=2019-01-19, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=632d1583337f, moduleTitle=Lancet Haematol：MYC基因重排侵袭性B细胞淋巴瘤可考虑剂量调整的EPOCH-R方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=632d1583337f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273286, encodeId=cf6e12e3286df, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=2018 B细胞靶向治疗自身免疫性疾病继发性低丙种球蛋白血症的管理建议, objectType=article, longId=157627, objectId=e6d115e62713, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6d115e62713, replyNumber=0, likeNumber=26, createdTime=2019-01-10, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6d115e62713, moduleTitle=2018 B细胞靶向治疗自身免疫性疾病继发性低丙种球蛋白血症的管理建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6d115e62713)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273285, encodeId=9cf712e32857c, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NEJM：Tisagenlecleucel治疗复发或难治性弥漫性大B细胞淋巴瘤II期结果显著, objectType=article, longId=157227, objectId=faef15e22769, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=faef15e22769, replyNumber=0, likeNumber=74, createdTime=2019-01-05, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=faef15e22769, moduleTitle=NEJM：Tisagenlecleucel治疗复发或难治性弥漫性大B细胞淋巴瘤II期结果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=faef15e22769)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273284, encodeId=68af12e3284d2, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=李志铭教授：疗效与安全性双赢--新型BTK抑制剂Zanubrutinib为B细胞淋巴瘤患者带来治疗新选择, objectType=article, longId=157138, objectId=55df15e138c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55df15e138c5, replyNumber=0, likeNumber=59, createdTime=2019-01-02, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55df15e138c5, moduleTitle=李志铭教授：疗效与安全性双赢--新型BTK抑制剂Zanubrutinib为B细胞淋巴瘤患者带来治疗新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55df15e138c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273283, encodeId=bc4c12e3283c3, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=邹德慧教授：Zanubrutinib在套细胞淋巴瘤（MCL）等多种B细胞淋巴瘤中应用前景广阔，成为我国自主研发药的重大里程碑, objectType=article, longId=156972, objectId=67fa1569e267, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67fa1569e267, replyNumber=0, likeNumber=108, createdTime=2018-12-31, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67fa1569e267, moduleTitle=邹德慧教授：Zanubrutinib在套细胞淋巴瘤（MCL）等多种B细胞淋巴瘤中应用前景广阔，成为我国自主研发药的重大里程碑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67fa1569e267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273282, encodeId=6d1a12e328259, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=ARCH PATHOL LAB MED：通过下一代测序建立克隆亲缘的解剖学和时间上不同的B细胞淋巴瘤样品的分子指纹图谱, objectType=article, longId=156961, objectId=68ee15696125, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68ee15696125, replyNumber=0, likeNumber=70, createdTime=2018-12-31, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68ee15696125, moduleTitle=ARCH PATHOL LAB MED：通过下一代测序建立克隆亲缘的解剖学和时间上不同的B细胞淋巴瘤样品的分子指纹图谱, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68ee15696125)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273281, encodeId=296312e328182, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=CLIN CANCER RES：Tisagenlecleucel治疗B细胞急性淋巴细胞白血病的临床药理学, objectType=article, longId=156351, objectId=2df2156351e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2df2156351e6, replyNumber=0, likeNumber=89, createdTime=2018-12-23, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2df2156351e6, moduleTitle=CLIN CANCER RES：Tisagenlecleucel治疗B细胞急性淋巴细胞白血病的临床药理学, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2df2156351e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

B细胞

2020-05-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：Parsaclisib，高选择性PI3Kδ抑制剂，可有效治疗复发性或难治性B细胞NHL

2019-04-03

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

NCCN临床实践指南：B细胞淋巴瘤（2019.V2）

2019-04-01

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：Venetoclax联合R-CHOP可安全有效治疗弥漫性大B细胞淋巴瘤

2019-03-25

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Ann Rheum Dis：使用靶向B细胞的ianalumab（VAY736）治疗原发性干燥综合征

2019-03-07

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

鞍区粘膜相关性B细胞淋巴瘤1例

2019-02-27

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

加拿大批准Yescarta（Axicabtagene Ciloleucel）CAR T疗法治疗成人复发或难治性大B细胞淋巴瘤

2019-02-25

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

AP&T：慢性乙型肝炎会增加B细胞非霍奇金淋巴瘤和多发性骨髓瘤发生风险

2019-02-18

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Stem Cell Reports：科学家在小鼠体内制造出可供移植功能性B细胞

2019-02-16

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：MHC II类细胞可自主调节正常和恶性B细胞的自我更新和分化

2019-02-09

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

INT J LAB HEMATOL：利用CD81/CD58的表达率很容易从B细胞祖细胞急性淋巴细胞白血病患者淋巴母细胞中识别造血细胞

2019-02-03

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

INT J LAB HEMATOL：对286个成熟B细胞肿瘤的整合流式细胞术分析显示，CD13可作为诊断亚型的有用标记

2019-02-03

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

2019 BSH更佳实践指南：原发性纵膈B细胞淋巴瘤的管理

2019-01-30

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

膀胱弥漫大B细胞淋巴瘤侵及回肠1例

2019-01-25

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Lancet Haematol：MYC基因重排侵袭性B细胞淋巴瘤可考虑剂量调整的EPOCH-R方案

2019-01-19

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

2018 B细胞靶向治疗自身免疫性疾病继发性低丙种球蛋白血症的管理建议

2019-01-10

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

NEJM：Tisagenlecleucel治疗复发或难治性弥漫性大B细胞淋巴瘤II期结果显著

2019-01-05

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

李志铭教授：疗效与安全性双赢--新型BTK抑制剂Zanubrutinib为B细胞淋巴瘤患者带来治疗新选择

2019-01-02

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

邹德慧教授：Zanubrutinib在套细胞淋巴瘤（MCL）等多种B细胞淋巴瘤中应用前景广阔，成为我国自主研发药的重大里程碑

2018-12-31

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

ARCH PATHOL LAB MED：通过下一代测序建立克隆亲缘的解剖学和时间上不同的B细胞淋巴瘤样品的分子指纹图谱

2018-12-31

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

CLIN CANCER RES：Tisagenlecleucel治疗B细胞急性淋巴细胞白血病的临床药理学

2018-12-23

科室
- - 订阅+
  - 更多科室
工具
服务